Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-03-24, Stock:ABBV, The news for the past five days is as follows:
2021-03-17: NEWS1: Did Pfizer Just Trip Up AbbVie's Chances For A New Arthritis Drug?.NEWS2: FDA Pushback on AbbVie Drug Raises More Alarms for Biotechnology.NEWS3: REFILE-UPDATE 1-U.S. FDA extends review period for expanded use of Abbvie's arthritis drug.NEWS4: U.S. FDA extends review period for expanded use of Abbvie's arthritis drug.NEWS5: AbbVie Announces Extension of Review for Supplemental New Drug Application of Upadacitinib for the Treatment of Adults with Active Psoriatic Arthritis.NEWS6: The FTC Is Taking a More Aggressive Approach Toward Pharmaceutical M&A. What It Means for the Industry..NEWS7: AbbVie Slumps After FDA Extends Psoriatic Arthritis Drug Review.NEWS8: 4 Pharma Stocks That Could Be Losers With the $1.9 Trillion Stimulus Package.
2021-03-18: NEWS1: SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AbbVie Inc. - ABBV.NEWS2: ETF looks to help private sector address women’s issues.NEWS3: AbbVie (ABBV) Down as FDA Extends Review of Rinvoq sNDA.NEWS4: Pharma Stock Roundup: J&J, AZN COVID-19 Update, FDA Delays Decision on ABBV's sNDA.
2021-03-19: NEWS1: 5 High Dividend Yield Stocks Broadly Bought by Gurus.NEWS2: Alpine Immune Sciences, Inc. (ALPN) Q4 2020 Earnings Call Transcript.
2021-03-22: NEWS1: 'Halftime Report' Final Trades: Roku, AbbVie And More.NEWS2: 3 High-Yield Dividend Stocks Billionaires Can't Stop Buying.NEWS3: SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AbbVie Inc. - ABBV.
2021-03-23: NEWS1: AbbVie (ABBV) Dips More Than Broader Markets: What You Should Know.

Answer: Decrease